Harleysville, PA, United States of America

Joseph E Pero

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph E Pero. Retrieved from https://idiyas.com/inventor/joseph-e-pero-bynnz6iz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Joseph E. Pero: A Pioneer in Pain Management

Introduction

Joseph E. Pero is a distinguished inventor based in Harleysville, Pennsylvania, who has made significant contributions to the field of pharmacology. With a total of eight patents to his name, he has focused on creating compounds that target voltage-gated sodium channels, offering innovative solutions for pain management and other disorders.

Latest Patents

Joseph E. Pero's latest innovations include groundbreaking patents aimed at treating chronic pain and neuropathic disorders. One of his notable patents involves N1-phenylpropane-1,2-diamine compounds, which exhibit selective activity in voltage-gated sodium channels. These compounds, outlined in Formula A-1, provide promising properties for inhibiting sodium ion channels found in peripheral and sympathetic neurons. The patent also discusses pharmaceutical formulations that incorporate these compounds and their potential applications in treating pain, cough, or itch disorders.

Another significant patent features benzoxazolinone compounds that also selectively target voltage-gated sodium channels. Defined in Formula A, these compounds are specifically designed to block Na1.7 ion channels found in peripheral and sympathetic neurons. The patent details various pharmaceutical formulations incorporating these compounds and describes methods for treating neuropathic pain disorders.

Career Highlights

Joseph E. Pero is currently associated with Merck Sharp & Dohme Corporation, where he continues to drive development in innovative pharmacological solutions. His extensive expertise in pharmacology and forward-thinking approach have made him a key player in advancing therapeutic options for patients suffering from chronic conditions.

Collaborations

During his career, Joseph has collaborated with talented professionals including Mark E. Layton and Michael A. Rossi. Together, they work on developing new therapeutic innovations, contributing to research and enhancing the efficacy of pain management strategies.

Conclusion

Joseph E. Pero is a noteworthy inventor whose work has a profound impact on the treatment of pain and various disorders. His dedication to research and development at Merck Sharp & Dohme Corporation exemplifies the vital role inventors play in advancing medical therapies. With eight patents, his contributions will likely continue to influence the pharmaceutical industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…